Eligo is pioneering a platform that engineers phage-derived particles, known as Eligobiotics, to deliver modular therapeutic DNA payloads for precision microbiome editing. Targeting inflammatory diseases, infectious diseases, and oncology, Eligo's technology offers innovative solutions that address significant unmet medical needs.
No jobs found. Subscribe below to get notified when we find something for you.
Searching